Stempeutics Research, part of Manipal Education & Medical has now commenced the development of an innovative point-of-care, fully automated stem cell isolation device ‘Stempeutron’ which is a boon for plastic and cosmetic surgeons. The device first time being developed in India, can be used for breast reconstruction/cosmetic breast augmentation, facial restructuring, deformity correction, scar and wrinkle reduction. The device which has proved its engineering functionality and commercial viability will now need a strategic partner for which Stempeutics is gearing up to initiate dialogue with global medical device majors like GE, Siemens, Phillips and J&J, BN Manohar, CEO, Stempeutics Research told Pharmabiz.
